Literature DB >> 29274296

T cell exhaustion in cancer: Mechanisms and clinical implications.

Jin-Cheng Wang1, Yong Xu2, Zheng-Ming Huang3, Xiao-Jie Lu1.   

Abstract

During chronic viral infection or cancer, the immune system usually induces a corresponding immune response against pathogens or cancer cells so as to prevent worsening disease. T cell exhaustion in which reduced and dysfunctional effector T cells lead to immune escape is one of the mechanisms that pathogens or cancer cells get rid of control from the immune system. In this review, we discuss some mechanisms associated with T cell exhaustion and enumerate current methods of reversing T cell exhaustion. We also summarize current targeted treatment strategies and put forward following aspects that required to research.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  T cell exhaustion; cancer; inhibitory receptors; reversal; treatment strategy

Mesh:

Year:  2018        PMID: 29274296     DOI: 10.1002/jcb.26645

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.

Authors:  X Liu; H Ren; H Guo; W Wang; N Zhao
Journal:  Clin Exp Immunol       Date:  2020-10-26       Impact factor: 4.330

2.  Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer.

Authors:  Jae Won Yun; Soomin Lee; Daeun Ryu; Semi Park; Woong-Yang Park; Je-Gun Joung; Jeongyun Jeong
Journal:  Transl Oncol       Date:  2018-09-25       Impact factor: 4.243

3.  Linking Binary Gene Relationships to Drivers of Renal Cell Carcinoma Reveals Convergent Function in Alternate Tumor Progression Paths.

Authors:  William L Poehlman; James J Hsieh; F Alex Feltus
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

4.  Tumor Arrests DN2 to DN3 Pro T Cell Transition and Promotes Its Conversion to Thymic Dendritic Cells by Reciprocally Regulating Notch1 and Ikaros Signaling.

Authors:  Ipsita Guha; Avishek Bhuniya; Divanshu Shukla; Ashok Patidar; Partha Nandi; Akata Saha; Shayani Dasgupta; Nilanjan Ganguly; Sweta Ghosh; Arathi Nair; Subrata Majumdar; Bhaskar Saha; Walter J Storkus; Rathindranath Baral; Anamika Bose
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

Review 5.  Endoplasmic Reticulum Stress Pathway, the Unfolded Protein Response, Modulates Immune Function in the Tumor Microenvironment to Impact Tumor Progression and Therapeutic Response.

Authors:  Manuel U Ramirez; Salvador R Hernandez; David R Soto-Pantoja; Katherine L Cook
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

6.  Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families.

Authors:  S Yado; G Luboshits; O Hazan; R Or; M A Firer
Journal:  J Immunother Cancer       Date:  2019-11-14       Impact factor: 13.751

7.  Inhibition of galectin-3 augments the antitumor efficacy of PD-L1 blockade in non-small-cell lung cancer.

Authors:  Hongxin Zhang; Pengfei Liu; Yan Zhang; Lujun Han; Zhihui Hu; Ziqi Cai; Jianhui Cai
Journal:  FEBS Open Bio       Date:  2021-01-31       Impact factor: 2.693

8.  Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.

Authors:  Lan Yu; Yi Ding; Ting Wan; Ting Deng; He Huang; Jihong Liu
Journal:  Front Immunol       Date:  2021-12-13       Impact factor: 7.561

Review 9.  Traditional Chinese Medicine Therapy for Esophageal Cancer: A Literature Review.

Authors:  Luchang Cao; Xinmiao Wang; Guanghui Zhu; Shixin Li; Heping Wang; Jingyuan Wu; Taicheng Lu; Jie Li
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

10.  Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma.

Authors:  Junsheng Zhao; Zhongli Yang; Mingmin Tu; Wei Meng; Hainv Gao; Ming D Li; Lanjuan Li
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.